Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1198

1.

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

Schuler M, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JC, Lee KH, Lu S, Shi Y, Kim SW, Laskin J, Kim DW, Arvis CD, Kölbeck K, Massey D, Märten A, Paz-Ares L, Park K.

J Cancer Res Clin Oncol. 2019 Feb 19. doi: 10.1007/s00432-019-02862-x. [Epub ahead of print]

PMID:
30783814
2.

Application of Data-Independent Acquisition Approach to Study the Proteome Change from Early to Later Phases of Tomato Pathogenesis Responses.

Fan KT, Wang KH, Chang WH, Yang JC, Yeh CF, Cheng KT, Hung SC, Chen YR.

Int J Mol Sci. 2019 Feb 17;20(4). pii: E863. doi: 10.3390/ijms20040863.

3.

Circ-VANGL1 promotes the progression of osteoporosis by absorbing miRNA-217 to regulate RUNX2 expression.

Yang L, Zeng Z, Kang N, Yang JC, Wei X, Hai Y.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):949-957. doi: 10.26355/eurrev_201902_16981.

PMID:
30779060
4.

[Surgical results and sagittal alignment analysis of different fusion levels for degenerative scoliosis].

Meng XL, Hai Y, Xu G, Yang JC, Su QJ.

Zhonghua Yi Xue Za Zhi. 2019 Jan 29;99(5):359-364. doi: 10.3760/cma.j.issn.0376-2491.2019.05.008. Chinese.

PMID:
30772977
5.

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors.

Doi T, Yang JC, Shitara K, Naito Y, Cheng AL, Sarashina A, Pronk LC, Takeuchi Y, Lin CC.

Target Oncol. 2019 Feb 6. doi: 10.1007/s11523-019-00620-0. [Epub ahead of print]

PMID:
30725402
6.

Transition-metal free C-C bond cleavage/borylation of cycloketone oxime esters.

Zhang JJ, Duan XH, Wu Y, Yang JC, Guo LN.

Chem Sci. 2018 Oct 2;10(1):161-166. doi: 10.1039/c8sc03315c. eCollection 2019 Jan 7.

7.

The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments.

Johnson FR, Yang JC, Reed SD.

Value Health. 2019 Feb;22(2):157-160. doi: 10.1016/j.jval.2018.07.876. Epub 2018 Sep 27.

PMID:
30711059
8.

Preferences of women with epithelial ovarian cancer for aspects of genetic testing.

Davidson BA, Ehrisman J, Reed SD, Yang JC, Buchanan A, Havrilesky LJ.

Gynecol Oncol Res Pract. 2019 Jan 22;6:1. doi: 10.1186/s40661-019-0066-8. eCollection 2019.

9.

Brain Activation Patterns Associated with the Effects of Fearful Distractors during Working Memory Maintenance in Patients with Schizophrenia.

Park JI, Kim GW, Jeong GW, Yang JC.

Clin Psychopharmacol Neurosci. 2019 Feb 28;17(1):54-63. doi: 10.9758/cpn.2019.17.1.54.

10.

Shape of a skyrmion.

Yang JC, Mao QQ, Shi Y.

J Phys Condens Matter. 2019 Jan 25;31(16):165802. doi: 10.1088/1361-648X/ab01ef. [Epub ahead of print]

PMID:
30681977
11.

[Introduction on 'assessing the risk of bias of individual studies' in systematic review of health-care intervention programs revised by the Agency for Healthcare Research and Quality].

Yang JC, Yang ZR, Yu SQ, Zhan SY, Sun F.

Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jan 10;40(1):106-111. doi: 10.3760/cma.j.issn.0254-6450.2019.01.021. Chinese.

PMID:
30669741
12.

Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.

Chien CM, Yang JC, Wu PH, Wu CY, Chen GY, Wu YC, Chou CK, Tseng CH, Chen YL, Wang LF, Chiu CC.

Phytomedicine. 2018 Jun 28;54:109-119. doi: 10.1016/j.phymed.2018.06.025. [Epub ahead of print]

PMID:
30668360
13.

Microsurgical head and neck reconstruction in patients with coronary artery disease: A perioperative assessment algorithm.

Scaglioni MT, Giovanoli P, Scaglioni MF, Yang JC.

Microsurgery. 2019 Jan 15. doi: 10.1002/micr.30429. [Epub ahead of print]

PMID:
30648284
14.

Multidisciplinary Care is the Best Approach, Anytime.

Yang JC.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):296. doi: 10.1016/j.ijrobp.2018.09.045. No abstract available.

PMID:
30647005
15.

Brachytherapy Training Survey of Radiation Oncology Residents.

Marcrom SR, Kahn JM, Colbert LE, Freese CM, Doke KN, Yang JC, Yashar CM, Luu M, Kamrava M.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):557-560. doi: 10.1016/j.ijrobp.2018.10.023. Epub 2018 Oct 26.

PMID:
30612963
16.

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.

Wu YL, Planchard D, Lu S, Sun H, Yamamoto N, Kim DW, Tan DSW, Yang JC, Azrif M, Mitsudomi T, Park K, Soo RA, Chang JWC, Alip A, Peters S, Douillard JY.

Ann Oncol. 2019 Feb 1;30(2):171-210. doi: 10.1093/annonc/mdy554.

PMID:
30596843
17.

Highly Ordered 3D Microstructure Based Electronic Skin Capable of Differentiating Pressure, Temperature, and Proximity.

Kim JO, Kwon SY, Kim Y, Choi HB, Yang JC, Oh J, Lee HS, Sim JY, Ryu S, Park S.

ACS Appl Mater Interfaces. 2018 Dec 19. doi: 10.1021/acsami.8b19214. [Epub ahead of print]

PMID:
30565915
18.

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation.

Yang JC, Gadgeel SM, Sequist LV, Wu CL, Papadimitrakopoulou VA, Su WC, Fiore J, Saraf S, Raftopoulos H, Patnaik A.

J Thorac Oncol. 2019 Mar;14(3):553-559. doi: 10.1016/j.jtho.2018.11.028. Epub 2018 Dec 4.

PMID:
30529597
19.

[Percutaneous endoscopic transforaminal lumbar interbody fusion for lumbar spinal stenosis].

Yang JC, Hai Y, Ding Y, Yin P, Zhang YS, Liu C, Zhang LM.

Zhonghua Yi Xue Za Zhi. 2018 Dec 4;98(45):3711-3715. doi: 10.3760/cma.j.issn.0376-2491.2018.45.016. Chinese.

PMID:
30526785
20.

A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers.

Stevanovic S, Helman SR, Wunderlich JR, Doran SL, Langhan MM, Kwong MLM, Somerville RPT, Klebanoff CA, Kammula U, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS.

Clin Cancer Res. 2018 Dec 5. pii: clincanres.2722.2018. doi: 10.1158/1078-0432.CCR-18-2722. [Epub ahead of print]

PMID:
30518633
21.

Transcriptome Analysis of Oleoresin-Producing Tree Sindora Glabra and Characterization of Sesquiterpene Synthases.

Yu N, Yang JC, Yin GT, Li RS, Zou WT.

Front Plant Sci. 2018 Nov 20;9:1619. doi: 10.3389/fpls.2018.01619. eCollection 2018.

22.

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-Term follow-up from a pooled analysis of 2 phase 2 studies.

Ahn MJ, Tsai CM, Shepherd FA, Bazhenova L, Sequist LV, Hida T, Yang JCH, Ramalingam SS, Mitsudomi T, Jänne PA, Mann H, Cantarini M, Goss G.

Cancer. 2018 Dec 4. doi: 10.1002/cncr.31891. [Epub ahead of print]

PMID:
30512189
23.
24.
25.

Reply: Ultrasound Technology in Targeting Reflux-Free Venules for Optimal Lymphaticovenular Anastomosis in the Treatment of Lymphedema.

Yang JC.

Plast Reconstr Surg. 2018 Dec;142(6):985e. doi: 10.1097/PRS.0000000000005034. No abstract available.

PMID:
30496153
26.

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.

Lin YT, Chen JS, Liao WY, Ho CC, Hsu CL, Yang CY, Chen KY, Lee JH, Lin ZZ, Shih JY, Yang JC, Yu CJ.

Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32025. [Epub ahead of print]

PMID:
30485437
27.

Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer.

Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande PV, Efstathiou JA.

Clin Genitourin Cancer. 2019 Feb;17(1):23-31.e3. doi: 10.1016/j.clgc.2018.09.023. Epub 2018 Oct 4.

PMID:
30482661
28.

Structural characterization of heterogeneous RhAu nanoparticles from a microwave-assisted synthesis.

Duan Z, Timoshenko J, Kunal P, House SD, Wan H, Jarvis K, Bonifacio C, Yang JC, Crooks RM, Frenkel AI, Humphrey SM, Henkelman G.

Nanoscale. 2018 Dec 21;10(47):22520-22532. doi: 10.1039/c8nr04866e. Epub 2018 Nov 27.

PMID:
30480291
29.

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer.

Liu C, Lou W, Yang JC, Liu L, Armstrong CM, Lombard AP, Zhao R, Noel ODV, Tepper CG, Chen HW, Dall'Era M, Evans CP, Gao AC.

Nat Commun. 2018 Nov 16;9(1):4700. doi: 10.1038/s41467-018-07178-x.

30.

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Gadgeel SM, Stevenson JP, Langer CJ, Gandhi L, Borghaei H, Patnaik A, Villaruz LC, Gubens M, Hauke R, Yang JC, Sequist LV, Bachman R, Saraf S, Raftopoulos H, Papadimitrakopoulou V.

Lung Cancer. 2018 Nov;125:273-281. doi: 10.1016/j.lungcan.2018.08.019. Epub 2018 Aug 25.

PMID:
30429032
31.

Ultrafast Giant Photostriction of Epitaxial Strontium Iridate Film with Superior Endurance.

Yang JC, Liou YD, Tzeng WY, Liu HJ, Chang YW, Xiang PH, Zhang Z, Duan CG, Luo CW, Chen YC, Chu YH.

Nano Lett. 2018 Nov 12. doi: 10.1021/acs.nanolett.8b03435. [Epub ahead of print]

PMID:
30407834
32.

A Practical Electrophilic Nitrogen Source for the Synthesis of Chiral Primary Amines by Copper-Catalyzed Hydroamination.

Guo S, Yang JC, Buchwald SL.

J Am Chem Soc. 2018 Nov 21;140(46):15976-15984. doi: 10.1021/jacs.8b10564. Epub 2018 Nov 8.

PMID:
30371077
33.

Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study.

Hochmair MJ, Morabito A, Hao D, Yang CT, Soo RA, Yang JC, Gucalp R, Halmos B, Wang L, Golembesky A, Märten A, Cufer T.

Future Oncol. 2018 Nov;14(27):2861-2874. doi: 10.2217/fon-2018-0711. Epub 2018 Oct 19.

34.

A Facile Measurement for Monitoring Dragline Silk Dope Concentration in Nephila pilipes upon Spinning.

Wu HC, Wu SR, Yang TC, Yang JC.

Materials (Basel). 2018 Oct 12;11(10). pii: E1951. doi: 10.3390/ma11101951.

35.

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer.

Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM.

J Oncol Pract. 2018 Oct;14(10):580-587. doi: 10.1200/JOP.18.00178.

PMID:
30312560
36.

An "all-in-one" antitumor and anti-recurrence/metastasis nanomedicine with multi-drug co-loading and burst drug release for multi-modality therapy.

Yang JC, Shang Y, Li YH, Cui Y, Yin XB.

Chem Sci. 2018 Jul 30;9(36):7210-7217. doi: 10.1039/c8sc02305k. eCollection 2018 Sep 28.

37.

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

Camidge DR, Kim HR, Ahn MJ, Yang JC, Han JY, Lee JS, Hochmair MJ, Li JY, Chang GC, Lee KH, Gridelli C, Delmonte A, Garcia Campelo R, Kim DW, Bearz A, Griesinger F, Morabito A, Felip E, Califano R, Ghosh S, Spira A, Gettinger SN, Tiseo M, Gupta N, Haney J, Kerstein D, Popat S.

N Engl J Med. 2018 Nov 22;379(21):2027-2039. doi: 10.1056/NEJMoa1810171. Epub 2018 Sep 25.

PMID:
30280657
38.

Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism.

Wang XH, Yang JC, Soohoo R, Cotter D, Yuan M, Xia J, Yaqub S, Doty J, Niu YQ, Tassone F, Hagerman R, Zhang L, Olichney J.

Front Genet. 2018 Sep 18;9:327. doi: 10.3389/fgene.2018.00327. eCollection 2018.

39.

Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population: A Cross-Sectional Study.

Guo YC, Zhou Y, Gao X, Yao Y, Geng B, Cui QH, Yang JC, Hu HP.

Chin Med J (Engl). 2018 Oct 5;131(19):2269-2276. doi: 10.4103/0366-6999.241797.

40.

Sintering Pmperature-Dependence on Radiopacity of Bi(2-x) ZrxO(3+x/2) Powders Prepared by Sol-Gel Process.

Chen MS, Chen SH, Lai FC, Chen CY, Hsieh MY, Chang WJ, Yang JC, Lin CK.

Materials (Basel). 2018 Sep 11;11(9). pii: E1685. doi: 10.3390/ma11091685.

41.

Intermittent subthalamic nucleus deep brain stimulation induces risk-aversive behavior in human subjects.

Patel SR, Herrington TM, Sheth SA, Mian M, Bick SK, Yang JC, Flaherty AW, Frank MJ, Widge AS, Dougherty D, Eskandar EN.

Elife. 2018 Sep 10;7. pii: e36460. doi: 10.7554/eLife.36460.

42.

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer.

Wu YL, Zhang L, Kim DW, Liu X, Lee DH, Yang JC, Ahn MJ, Vansteenkiste JF, Su WC, Felip E, Chia V, Glaser S, Pultar P, Zhao S, Peng B, Akimov M, Tan DSW.

J Clin Oncol. 2018 Nov 1;36(31):3101-3109. doi: 10.1200/JCO.2018.77.7326. Epub 2018 Aug 29. Erratum in: J Clin Oncol. 2019 Jan 20;37(3):261.

PMID:
30156984
43.

Early-Stage Follicular Lymphoma: What Is the Preferred Treatment Strategy?

Yang JC, Yahalom J.

J Clin Oncol. 2018 Oct 10;36(29):2904-2906. doi: 10.1200/JCO.2018.79.3075. Epub 2018 Aug 28. No abstract available.

PMID:
30153098
44.

New diterpenes leojaponins G-L from Leonurus japonicus.

Lai KY, Hu HC, Chiang HM, Liu YJ, Yang JC, Lin YA, Chen CJ, Chang YS, Lee CL.

Fitoterapia. 2018 Oct;130:125-133. doi: 10.1016/j.fitote.2018.08.014. Epub 2018 Aug 24.

PMID:
30149097
45.

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Borghaei H, Langer CJ, Gadgeel S, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI, Panwalkar A, Yang JC, Gubens M, Sequist LV, Awad MM, Fiore J, Saraf S, Keller SM, Gandhi L.

J Thorac Oncol. 2019 Jan;14(1):124-129. doi: 10.1016/j.jtho.2018.08.004. Epub 2018 Aug 21.

PMID:
30138764
46.

Commentary to "Targeting Reflux-free Vein Using Indocyanine Green Dye Angiography".

Yang JC.

Plast Reconstr Surg. 2018 Aug 14. doi: 10.1097/PRS.0000000000004933. [Epub ahead of print] No abstract available.

PMID:
30119115
47.

Reply to "Lymphedema Quality of Life Score (LeQOLiS): A Simple Method for Evaluation of Subjective Symptoms in Extremity Lymphedema Patients".

Yang JC.

Plast Reconstr Surg. 2018 Aug 14. doi: 10.1097/PRS.0000000000004938. [Epub ahead of print] No abstract available.

PMID:
30119112
48.

Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.

Wu SG, Liu YN, Yu CJ, Yang JC, Shih JY.

Genes Chromosomes Cancer. 2018 Oct;57(10):513-521. doi: 10.1002/gcc.22647. Epub 2018 Aug 14.

PMID:
30107055
49.

[Clinical effects of percutaneous endoscopic transforaminal decompression for the treatment of lumbar spinal stenosis].

Li LJ, Chang F, Hai Y, Yang JC, Xu C, Yuan J, Sun JQ, Wang QH, Ding SQ.

Zhongguo Gu Shang. 2018 Jul 25;31(7):617-620. doi: 10.3969/j.issn.1003-0034.2018.07.007. Chinese.

PMID:
30103584
50.

Interface Engineering of Gold Nanoclusters for CO Oxidation Catalysis.

Li Y, Chen Y, House SD, Zhao S, Wahab Z, Yang JC, Jin R.

ACS Appl Mater Interfaces. 2018 Sep 5;10(35):29425-29434. doi: 10.1021/acsami.8b07552. Epub 2018 Aug 22.

PMID:
30091579

Supplemental Content

Support Center